For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Eileen Goodwin
Eileen Goodwin

Freelance writer based in Dunedin
Articles by Eileen Goodwin
Pagination
Article archive
How to Treat
Wednesday 28 May 2025, 12:50 AM
Latest news
06/06/2025
Events
Latest issue
Most popular
06/06/2025
That's interesting
Gallery
National Rural Health Conference 2025 Gallery